en
jalali
1398
1
1
gregorian
2019
4
1
3
2
online
1
fulltext
en
Radiofrequency Electromagnetic Fields: Carcinogenic and Other Biological Effects
In the electromagnetic spectrum, structural damage to living tissues per unit of absorbed energy tends to increase with the decrease of a wavelength which is evident not only for ultraviolet and ionizing radiation but also for the infrared and visible light. By causing thermal damage after absorbing energies that would be harmless for radiofrequency electromagnetic fields (EMF), tissues are evenly heated. There are no prima facie reasons to expect more damage from EMF than from infrared radiation which is believed to be harmless in terms of thermal damage. Several studies reported possible associations between EMF, glioma and other tumors. Other research did not confirm such associations or even identified a reduced risk of brain tumors among mobile phone (MP) users. Anelevation in the application of MP has been observed in some countries and age groups which is out of proportion. Improving imaging technology and access to health care units have contributed to an increased incidence rate. Bias is known to occur in epidemiologic research. At the beginning of the MP era, the use of MP was associated with a high income which, in turn, must be associated with better diagnostics results. Admittedly, nowadays MPs are affordable for the majority of people and it is unclear whether the socioeconomic bias still plays a significant role. In conclusion, there is neither compelling evidence nor theoretic plausibility for the concept that EMF is more harmful than infrared radiation per unit of absorbed energy.
Electromagnetic Fields, Cell Phone, Neoplasms
5
13
http://mcijournal.com/browse.php?a_code=A-10-257-1&slc_lang=en&sid=1
2019/02/13
1397/11/24
2019/03/19
1397/12/28
Sergei
Jargin
Peoples' Friendship University of Russia
sjargin@mail.ru
0031947532846002125
0031947532846002125
Yes
en
Anticancer and Apoptotic Effects of Ectoine and Hydroxyectoine on Non-Small Cell Lung Cancer cells: An in-vitro Investigation
Introduction: Streptomyces manage the osmotic stress by collecting compatible solutes or osmolytes. Ectoine, 1,4,5,6-tetrahydro-2-methyl-4-pyrimidine carboxylic acid, and 5-hydroxyectoine are among the most common osmolytes of this bacteria and have an active role in protecting the genetic material of this microorganism as well as providing resistance to environmental pressures. In this research, the antiproliferative and apoptotic effects of ectoine and 5- hydroxyectoine on human non-small cell lung cancer (NSCLC) cell line (QU-DB) are investigated.
Methods: QU-DB cells were treated by five doses of ectoine and hydroxyectoine for 12, 24 and 48 hours, and the cytotoxic properties were evaluated by MTT assay. Then, the DAPI fluorescent staining was carried out for monitoring of the cells’nuclear morphology. Recognition and quantification of the apoptosis were done; using the Annexin-V-Fluos technique.
Results: It has been verified that both ectoine and hydroxyectoine persuaded apoptosis on QU-DB cells in a dose-dependently manner.
Conclusions: Ectoine and hydroxyectoine are two natural metabolites which induce apoptosis in lung cancer cells. They don’t have any toxic effect on normal cells and can be used as auxiliary drugs or even as a medicine for the treatment of lung cancer after further optimization of the formulations.
Ectoine, Hydroxyectoine, Lung Cancer Cells
14
19
http://mcijournal.com/browse.php?a_code=A-10-283-1&slc_lang=en&sid=1
2019/02/132019/02/4
1397/11/15
2019/03/192019/03/11
1397/12/20
Mojgan
Shaikhpour
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
m_sheikhpour@pasteur.ac.ir
0031947532846002150
0031947532846002150
Yes
Akram
Sadeghi
Microbial Biotechnology and Biosafety Department, Agricultural Biotechnology Research Institute of Iran (ABRII), Karaj, Iran
aksadeghi@abrii.ac.ir
0031947532846002151
0031947532846002151
No
Fatemeh
Yazdian
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran
Yazdian@ut.ac.ir
0031947532846002152
0031947532846002152
No
Ali
Mansoori
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran
mansoori.bio@gmail.com
0031947532846002153
0031947532846002153
No
Abolfazl
Movafagh
Department of Genetics, ,Shahid Beheshti University of Medical Sciences, Tehran, Iran
movafagh_a@yahoo.com
0031947532846002154
0031947532846002154
No
en
Functional Investigation of the Novel BRCA1variant (Glu1661Gly) byComputationalTools andYeastTranscription Activation Assay
Introduction: Mutations in the BRCA1 gene are major risk factors for breast and ovarian cancers. However, the relationship between some BRCA1 mutations and cancer risk remains largely unknown. Cancer risk predictions could be improved by evaluation of the impairment degree in the BRCA1 functions due to a specific mutation. This study aimed to assess the functional effect of a novel variant (Glu1661Gly) by a combination of in silico tools, structural analysis, and also experimental functional assay based on yeast transcription activation.
Methods: Computational tools including PROVEAN, PolyPhen2, Align-GVGD, Mutation Taster, and also structural analysis were used for prediction of the impact of Glu1661Gly on protein function. To perform the yeast functional assay, the BRCA1 C-terminal (BRCT domain) was cloned into pLexA plasmid in-frame with the DNA-binding domain of LexA to generate a functional transcription activator. The resulted construct was transformed into EGY48/ pRB1840 yeast and positive colonies were assayed for β-galactosidase activity. Wild-type BRCA1 and Ser1613Gly were used as positive controls and Met1775Arg as negative control.
Results: The Glu1661Gly variant was predicted to be neutral by PROVEAN, disease- causing by Mutation Taster, probably damaging by Polyphen2, and intermediate effect by Align-GVGD. The yeast functional assay revealed that Glu1661Gly activity was comparable to wild-type BRCA1
Conclusions: Observed discrepancies between in silico tools make it difficult to interpret the results. Based on structural analysis, the Glu1661Gly on α1 helix of the C-terminal domain does not seem to impair function due to α1 helix is far from the BRCT-BRCT interface and phosphopeptide-binding site. This variant was also classified as neutral; using yeast functional assay.
Susceptibility Genes, BRCA1, VUS, Glu1661Gly, Transcriptional Activation
20
26
http://mcijournal.com/browse.php?a_code=A-10-286-1&slc_lang=en&sid=1
2019/02/132019/02/42019/01/28
1397/11/8
2019/03/192019/03/112019/03/3
1397/12/12
Fatemeh
Yadegari
Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
yadegari1985@gmail.com
0031947532846003658
0031947532846003658
No
Leila
Farahmand
2 Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
laylafarahmand@gmail.com
0031947532846003659
0031947532846003659
No
Rezvan
Esmaeili
Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
esmaeili.rezvan@gmail.com
0031947532846003660
0031947532846003660
No
Shiva
Zarinfam
Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
sh.zarinfam@gmail.com
0031947532846003661
0031947532846003661
No
Keivan
Majidzadeh-A
Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
kmajidzadeh@razi.tums.ac.ir
0031947532846003662
0031947532846003662
Yes